找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Emerging Therapeutic Targets in Ovarian Cancer; Stan Kaye,Robert Brown,Martin Gore Book 2011 Springer Science+Business Media, LLC 2011

[复制链接]
查看: 49018|回复: 52
发表于 2025-3-21 19:37:58 | 显示全部楼层 |阅读模式
书目名称Emerging Therapeutic Targets in Ovarian Cancer
编辑Stan Kaye,Robert Brown,Martin Gore
视频video
概述Discusses the progress in linking the biology of ovarian cancer with novel targets and innovative therapies entering clinical trials..Provides an up-to-date perspective on successful therapeutic devel
图书封面Titlebook: Emerging Therapeutic Targets in Ovarian Cancer;  Stan Kaye,Robert Brown,Martin Gore Book 2011 Springer Science+Business Media, LLC 2011
描述.
出版日期Book 2011
版次1
doihttps://doi.org/10.1007/978-1-4419-7216-3
isbn_softcover978-1-4899-8233-9
isbn_ebook978-1-4419-7216-3
copyrightSpringer Science+Business Media, LLC 2011
The information of publication is updating

书目名称Emerging Therapeutic Targets in Ovarian Cancer影响因子(影响力)




书目名称Emerging Therapeutic Targets in Ovarian Cancer影响因子(影响力)学科排名




书目名称Emerging Therapeutic Targets in Ovarian Cancer网络公开度




书目名称Emerging Therapeutic Targets in Ovarian Cancer网络公开度学科排名




书目名称Emerging Therapeutic Targets in Ovarian Cancer被引频次




书目名称Emerging Therapeutic Targets in Ovarian Cancer被引频次学科排名




书目名称Emerging Therapeutic Targets in Ovarian Cancer年度引用




书目名称Emerging Therapeutic Targets in Ovarian Cancer年度引用学科排名




书目名称Emerging Therapeutic Targets in Ovarian Cancer读者反馈




书目名称Emerging Therapeutic Targets in Ovarian Cancer读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:18:20 | 显示全部楼层
发表于 2025-3-22 00:42:12 | 显示全部楼层
Epigenetic Therapies,d the achievement of a clear therapeutic index. In addition, the development of robust predictive biomarkers linked to an understanding of the underlying biology will be key to improved epigenetic therapy approaches. Defining the epigenetic alongside the genetic landscape of individual ovarian cance
发表于 2025-3-22 06:07:32 | 显示全部楼层
发表于 2025-3-22 10:09:48 | 显示全部楼层
发表于 2025-3-22 15:43:00 | 显示全部楼层
French Nuclear Command and Control,e in ovarian cancer and summarise the current progress in developing clinically applicable inhibitors of AKT pathway components for potential use in the ovarian cancer setting either alone or in combination with conventional cytotoxic agents such as the platinum drugs.
发表于 2025-3-22 20:09:08 | 显示全部楼层
发表于 2025-3-22 21:52:09 | 显示全部楼层
Specific Measurements, Units, and Termss have been implicated in T-cell suppression mediated by a number of cell surface molecules such as B7-H1 or enzymes such as arginase. Inflammation may be important in mediating suppression or defective response to treatment. Novel immune therapies have endeavoured to address immune suppression alon
发表于 2025-3-23 02:44:46 | 显示全部楼层
https://doi.org/10.1007/978-90-481-3411-3appears to reverse platinum-resistance, in part, by upregulation of caspase-3-mediated apoptosis. Src is an attractive target in ovarian cancers, and current trials using various Src inhibitors are underway.
发表于 2025-3-23 05:48:16 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-30 04:29
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表